PARP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.992800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.286600E-01
Normal-vs-Stage2
4.016800E-01
Normal-vs-Stage3
2.953200E-01
Normal-vs-Stage4
3.767400E-01
Stage1-vs-Stage2
8.003400E-01
Stage1-vs-Stage3
1.280830E-01
Stage1-vs-Stage4
6.844000E-01
Stage2-vs-Stage3
1.941960E-01
Stage2-vs-Stage4
5.133400E-01
Stage3-vs-Stage4
1.402360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.972000E-01
Normal-vs-AfricanAmerican
5.459600E-01
Normal-vs-Asian
3.711200E-01
Caucasian-vs-AfricanAmerican
1.463580E-01
Caucasian-vs-Asian
6.218400E-01
AfricanAmerican-vs-Asian
8.347700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.897400E-01
Normal-vs-Female
4.140800E-01
Male-vs-Female
4.304400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.274400E-01
Normal-vs-Age(41-60Yrs)
4.081800E-01
Normal-vs-Age(61-80Yrs)
3.980200E-01
Normal-vs-Age(81-100Yrs)
4.110600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.936400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.396000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.232400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.324200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.874600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.745600E-01
Normal-vs-Daily Drinker
3.284800E-01
Normal-vs-Weekly Drinker
3.881800E-01
Normal-vs-Occasional Drinker
4.719800E-01
Normal-vs-Social Drinker
4.240800E-01
Non Drinker-vs-Daily Drinker
3.511000E-01
Non Drinker-vs-Weekly Drinker
8.531200E-01
Non Drinker-vs-Occasional Drinker
1.375420E-01
Non Drinker-vs-Social Drinker
4.439800E-01
Daily Drinker-vs-Weekly Drinker
3.189800E-01
Daily Drinker-vs-Occasional Drinker
1.927680E-02
Daily Drinker-vs-Social Drinker
1.018830E-01
Weekly Drinker-vs-Occasional Drinker
2.529000E-01
Weekly Drinker-vs-Social Drinker
5.998800E-01
Occasional Drinker-vs-Social Drinker
5.043600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.893600E-01
Normal-vs-Grade 2
7.650000E-01
Normal-vs-Grade 3
7.305600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.351600E-01
Grade 1-vs-Grade 3
8.405000E-01
Grade 1-vs-Grade 4
4.893600E-01
Grade 2-vs-Grade 3
4.821800E-01
Grade 2-vs-Grade 4
7.650000E-01
Grade 3-vs-Grade 4
7.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.944400E-01
Normal-vs-NonDiabetic
3.840800E-01
Diabetic-vs-NonDiabetic
7.872400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.935200E-01
Normal-vs-NoPancreatitis
3.936200E-01
Pancreatitis-vs-NoPancreatitis
9.597400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.442200E-01
Normal-vs-N1
3.874000E-01
N0-vs-N1
1.118950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.914400E-01
Normal-vs-TP53-NonMutant
4.879400E-01
TP53-Mutant-vs-TP53-NonMutant
9.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
